Form 20-F TAKEDA PHARMACEUTICAL For: Mar 31
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260617/AALZ922CZ22QV2Z2222B2CZG2DSSZZ225C82
Filed on: June 17, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Takeda's Mimrylo for rare blood cancer polycythemia vera
- KBRA Assigns Rating to MSC Income Fund, Inc.'s $150 Million Senior Unsecured Notes Due 2029
- Young Americans Value Core Freedoms but View Today's Nation as 'Fractured'
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
